Cochrane Abstracts
Tocilizumab for giant cell arteritis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tocilizumab for Giant Cell Arteritis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439417/all/Tocilizumab_for_giant_cell_arteritis.
Tocilizumab for giant cell arteritis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439417/all/Tocilizumab_for_giant_cell_arteritis. Accessed January 31, 2025.
Tocilizumab for giant cell arteritis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439417/all/Tocilizumab_for_giant_cell_arteritis
Tocilizumab for Giant Cell Arteritis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439417/all/Tocilizumab_for_giant_cell_arteritis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tocilizumab for giant cell arteritis
ID - 439417
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439417/all/Tocilizumab_for_giant_cell_arteritis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
